Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.25 USD
100.78 M USD
838.00 M USD
170.31 M
About HUTCHMED (CHINA) LIMITED
Sector
CEO
Wei Guo Su
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG00B6VCGJ1
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.